C
Castle Biosciences, Inc. (CSTL)
NGM – Real Time Price. Currency in USD
18.29
-0.34 (-1.85%)
Market open: May 13, 2026, 9:44 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
18.29
-0.34 (-1.85%)
Market open: May 13, 2026, 9:44 AM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.75 | 2.46 | 10 | |
| Quick ratio | 6.53 | 2.06 | 10 | |
| Debt to Equity | 0.08 | -0.13 | 9.0 | |
| Debt to Assets | 0.07 | 1.87 | 9.0 | |
| Interest coverage | -137.37 | 4.31 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 137M | 220M | 332M | 344M | 340M |
| Gross Profit | 95M | 164M | 259M | 236M | 254M |
| Operating Income | -91M | -68M | 9M | -43M | -33M |
| Net Income | -67M | -57M | 18M | -24M | -13M |
| EBITDA | -81M | -56M | 25M | -2M | -18M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 0.11 | -347.5 | 1.5 |
| Next quarter | 9 | -1131.25 | 3.5 |
| Current year | 2.19 | -61.6 | 2.0 |
| Next year | 11.58 | 39.79 | 8.5 |
| Weighted average score | 3.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -3.82 | -522.72 | -512.49 | -275.13 | 1.0 |
| Y/Y | -4.89 | 43.82 | 45.56 | -220.93 | 5.5 |
| 3y average | 38.38 | -28.74 | -29.27 | 149.94 | 5.5 |
| 5y average | 42.19 | -81 | -65.09 | -38.76 | 3.3 |
| Weighted average score | 3.8 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $63.8M significantly exceed its total debt $36.7M, ensuring strong financial flexibility
Total current assets $328.9M exceed Total current liabilities $48.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (-0.1), showcasing prudent financial management
Interest coverage ratio (-137.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$34.6M limits the company's ability to reinvest or pay down debt